AIMS: To estimate the nationwide prevalence of diagnosed and undiagnosed diabetes and pre-diabetes in adults residing in France. METHODS: A probability sample of a non-institutionalized civilian population residing throughout the whole of continental France was recruited from February 2006 to March 2007 for the French Nutrition and Health Survey. All individuals aged between 18 and 74 years who agreed to participate in the survey were included; thus there were 3115 participants, 2102 of whom were undergoing biochemical assessments. The prevalence of diagnosed diabetes was estimated using self-reported diabetes history and the prevalence of undiagnosed diabetes was estimated using fasting plasma glucose ≥ 7.0 mmol/l or HbA(1c) ≥ 6.5% (≥ 48 mmol/mol). RESULTS: The prevalence of diagnosed diabetes was 4.6%, 95% CI 3.6-5.7. The prevalence of undiagnosed diabetes according to standard fasting plasma glucose criteria was 1% (95% CI 0.6-1.7) and contributed to less than 20% of all cases of diabetes. This proportion decreased with age from 30% in 30- to 54-year-olds to 12% in 55- to 74-year-olds. Based on HbA(1c) criteria, the prevalence of undiagnosed diabetes was 0.8% (95% CI 0.4-1.6). CONCLUSIONS: The prevalence of diagnosed diabetes in adults in France is comparable with recent estimates from Northern Europe. The percentage of total diabetes that is undiagnosed is low in France, which may be explained by a widely practised strategy of opportunist screening. During the past years, improvements in diabetes care and increased awareness may have contributed towards decreasing the prevalence of undiagnosed diabetes more widely in Europe, and studies should further monitor such improvements.
AIMS: To estimate the nationwide prevalence of diagnosed and undiagnosed diabetes and pre-diabetes in adults residing in France. METHODS: A probability sample of a non-institutionalized civilian population residing throughout the whole of continental France was recruited from February 2006 to March 2007 for the French Nutrition and Health Survey. All individuals aged between 18 and 74 years who agreed to participate in the survey were included; thus there were 3115 participants, 2102 of whom were undergoing biochemical assessments. The prevalence of diagnosed diabetes was estimated using self-reported diabetes history and the prevalence of undiagnosed diabetes was estimated using fasting plasma glucose ≥ 7.0 mmol/l or HbA(1c) ≥ 6.5% (≥ 48 mmol/mol). RESULTS: The prevalence of diagnosed diabetes was 4.6%, 95% CI 3.6-5.7. The prevalence of undiagnosed diabetes according to standard fasting plasma glucose criteria was 1% (95% CI 0.6-1.7) and contributed to less than 20% of all cases of diabetes. This proportion decreased with age from 30% in 30- to 54-year-olds to 12% in 55- to 74-year-olds. Based on HbA(1c) criteria, the prevalence of undiagnosed diabetes was 0.8% (95% CI 0.4-1.6). CONCLUSIONS: The prevalence of diagnosed diabetes in adults in France is comparable with recent estimates from Northern Europe. The percentage of total diabetes that is undiagnosed is low in France, which may be explained by a widely practised strategy of opportunist screening. During the past years, improvements in diabetes care and increased awareness may have contributed towards decreasing the prevalence of undiagnosed diabetes more widely in Europe, and studies should further monitor such improvements.
Authors: M Vernay; B Salanave; C de Peretti; C Druet; A Malon; V Deschamps; S Hercberg; K Castetbon Journal: Int J Public Health Date: 2013-09-03 Impact factor: 3.380
Authors: Anne Philippi; Sandra Heller; Ivan G Costa; Valérie Senée; Marc Nicolino; Cécile Julier; Alexander Kleger; Markus Breunig; Zhijian Li; Gino Kwon; Ronan Russell; Anett Illing; Qiong Lin; Meike Hohwieler; Anne Degavre; Pierre Zalloua; Stefan Liebau; Michael Schuster; Johannes Krumm; Xi Zhang; Ryan Geusz; Jacqueline R Benthuysen; Allen Wang; Joshua Chiou; Kyle Gaulton; Heike Neubauer; Eric Simon; Thomas Klein; Martin Wagner; Gopika Nair; Céline Besse; Claire Dandine-Roulland; Robert Olaso; Jean-François Deleuze; Bernhard Kuster; Matthias Hebrok; Thomas Seufferlein; Maike Sander; Bernhard O Boehm; Franz Oswald Journal: Nat Med Date: 2021-10-18 Impact factor: 87.241
Authors: Yong Du; Christin Heidemann; Antje Gößwald; Patrick Schmich; Christa Scheidt-Nave Journal: BMC Public Health Date: 2013-02-23 Impact factor: 3.295
Authors: Kate Junker; Claire M Buckley; Seán R Millar; Sinéad Flynn; Janas M Harrington; Patricia M Kearney; Ivan J Perry Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240
Authors: Kevin P Balanda; Claire M Buckley; Steve J Barron; Lorraine E Fahy; Jamie M Madden; Janas M Harrington; Ivan J Perry; Patricia M Kearney Journal: PLoS One Date: 2013-10-16 Impact factor: 3.240